期刊文献+

ANCA相关性小血管炎肾脏病理与临床表现相关性的初步分析——单中心回顾性研究

下载PDF
导出
摘要 目的:将本中心26例患者的病历资料进行分析,讨论小血管炎患者肾脏病理与临床表现的相关性。方法:选取2010年10月—2013年9月在我院因临床怀疑小血管炎而进行肾脏活检的患者22例,回顾性分析患者的临床表现和病理资料之间的相关性。结果:16例抗中性粒细胞胞浆抗体(ANCA)阳性、临床表现偏重的患者,肾脏病理均提示坏死性血管炎或新月体。2例临床表现较重、ANCA阴性的患者,病理表现为坏死性血管炎和III型新月体性肾炎,4例患者肾脏表现轻、ANCA阴性患者,肾脏病理未发现血管炎的证据。结论:ANCA阳性、临床症状相对较重,尤其是尿蛋白较多、出现过Scr异常的患者,肾脏病理易于发现小血管炎的相应证据。
出处 《内蒙古中医药》 2014年第15期101-102,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
  • 相关文献

参考文献7

  • 1Ntatsaki E,Watts RA,Scott DG.Epidemiology of ANCA-associated vasculitis.Rheum Dis Clin North Am.2010.36(3):447-61.
  • 2赵明辉.抗中性粒细胞胞浆抗体相关性小血管炎诊断和治疗几点体会[J].肾脏病与透析肾移植杂志,2004,13(6):548-549. 被引量:10
  • 3Xin G,Zhao MH,Wang HY.Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.Clinical and diagnostic laboratory immunology.2004.11(3):559-62.
  • 4Hagen EC,Daha MR,Hermans J,et al.Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis.EC/BCR Project for ANCA Assay Standardization.Kidney Int.1998.53(3):743-53.
  • 5Cui Z,Zhao MH,Segelmark M,Hellmark T.Natural autoantibodies to myeloperoxidase,proteinase 3,and the glomerular basement membrane are present in normal individuals.Kidney Int.2010.78(6):590-7.
  • 6薛超,卜昆鹏,廖蕴华.54例原发ANCA相关性小血管炎的肾脏病理及预后的分析[J].中国实验诊断学,2011,15(9):1528-1530. 被引量:9
  • 7Cao X,Lin W.Clinical study of renal impairment in patients with propylthiouracil-induced small-vessel vasculitis and patients with primary ANCA-associated small-vessel vasculitis.Exp Ther Med.2013.5(6):1619-1622.

二级参考文献10

  • 1Falk RJ,Jennette JC.Thoughts about the classification of small vessel vasculitis[J].J Nephrol,2004,17 (8):S3.
  • 2Jennette JC,Falk RJ,Andrassy K,et al.Nomenclature of systemic vasculitides.Proposal of an international consensus conference[J].Arthritis Rheum,1994,37(2):187.
  • 3Churg J,Bernstein J,Glassock RJ.Renal disease classification and atlas of glomerular-disease[M].Second edition.New York:Ikagu Shoin,1995,45-47.
  • 4Susan L,Hogan Ronald J,Falk H,et al.Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic Antibody–Associated Small-Vessel Vasculitis[J].Ann Intern Med,2005,143(9):621.
  • 5Chen M,Kallenberg CG.New advances in the pathogenesis of ANCA-associated vasculitides[J].Clin Exp Rheumatol,2009,27(1):S108.
  • 6Itabashi M,Yumura W,Tsukada M,et al.Clinico-histopathological analysis of renal changes in MPO-ANCA-associated vasculitis[J].Nippon Jinzo Gakkai Shi,2008,50(7):927.
  • 7Okano K,Yumura W,Nitta K,et al.Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody-(MPO-ANCA) associated glomerulonephritis[J].Clin Nephrol,2001,55(4):275.
  • 8Lionaki S,Hogan SL,Jennette CE,et al.The clinical course of ANCA small-vessel vasculitis on chronic dialysis[J].Kidney Int,2009,76(6):644.
  • 9Booth AD,Almond MK,Burns A,et al.Outcome of ANCA-associated renal vasculitis:a 5-year retrospective study[J].Am J Kidney Dis,2003,41(4):776.
  • 10Suzuki Y,Takeda Y,Sato D,et al.Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides:an 11-year retrospective hospital-based study in Japan[J].Mod Rheumatol,2010,20(1):54.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部